Clinical Trial

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to assess the safety and efficacy of AM3101 to facilitate meniscal repair and reduce the incidence of non-healing complications and morbidities associated with a failed meniscal repair. This is a prospective, randomized, controlled, double-blinded, multi-center study.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-09-27; most recent amendment 2026-04-28.
Status change: Not Yet Recruiting → Recruiting 2023-05-01
Trial Details
NCT Number NCT05560477
Lead Sponsor University of Cincinnati
Collaborators: United States Department of Defense
Conditions Meniscus Tear
Enrollment 74 participants
Start Date 2023-04-26
Primary Completion 2027-01 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-04